Clinical Ink, founded in 2011, is a global life science technology company that builds tools to digitize clinical research. Its core product, SureSource, is described as the industry's first purpose-built eSource platform, designed to replace paper documentation in clinical trials and reduce their associated cost and complexity.
The company's technical work spans several specialized domains: Direct Data Capture, electronic Clinical Outcome Assessments (eCOA), eConsent, telehealth, neurocognitive testing, and digital biomarkers. This breadth reflects a focus on building an integrated ecosystem for clinical trial data collection rather than isolated tools.
Clinical Ink operates across global markets, serving the life sciences, pharmaceutical research, and clinical trials sectors. The company's founding team brought over 40 years of combined experience in clinical research and medical forms publishing, and the organisation emphasises a patient-centric approach to research design.
